North America Dermal Filler Market share was valued at over USD 1.8 billion in 2019 and is expected to witness over 6.8% CAGR from 2020 to 2026.
Dermal fillers are injectables with gel-like substances used in various dermatological procedures. These are typically made up of fat and hyaluronic acid along with several other materials, having applications in skin volume restoration, enhancement of facial contours and smoothening of facial lines. Due to the increase in number of cosmetic procedures, dermatological clinics are witnessing significant demand for dermal fillers.
Get more details on this report - Request Free Sample PDF
Rising demand for cosmetic procedures to enhance facial appeal has led to increased product sales for dermatological treatments. As per the American Board of Cosmetic Surgery, over 1 million people opted for facial rejuvenation treatment. With growing demand for minimally invasive cosmetic procedures, the market is anticipated to foresee lucrative growth. For instance, according to the American Society of Plastic Surgery over 2 million soft tissue filler procedures were performed in 2017. Moreover, changing environmental factors and lifestyle resulting into faster skin aging along with rising elderly population are contributing to demand for facial aesthetics procedures. Additionally, increasing spending power of customers will stimulate North America dermal filler business growth in the forthcoming years.
North America Market, By Type
Biodegradable dermal filler segment dominated the market with over 86% revenue share in 2019 and is expected to witness similar trend over forecast years. High segmental value is attributable to various benefits offered by biodegradable material including polylactic acid such as non-toxicity and longer material shelf life. As per the Plastic Surgery Statistics by America Society of Plastic Surgeons, about 123,860 polylactic acid minimally invasive procedures were performed in 2017. Therefore, rise in procedural volume and product advantages will drive biodegradable dermal filler market growth over the analysis period.
North America Market, By Material Type
Hyaluronic acid (HA) dermal filler market was valued at over USD 1.2 billion in 2019 and will witness considerable growth during forecast period. Wide adoption of hyaluronic acid fillers in treatment of skin aging will impel the segment growth. The effectivity in slowing the process of natural aging will drive its preference among customers and dermatologists. Growing facial rejuvenation procedures leading to exponential increase in product demand over past few years will positively influence the segment revenue in the coming years.
North America Market, By Application
Facial line correction segment accounted for more than 43% market share in 2019 and is expected to grow momentously over forecast timeframe. Wrinkles and skin folds are among the most common conditions in some adults and elderly population. Thus, growing geriatric population will drive the demand for wrinkle treatment. Furthermore, exposure to ultraviolet light, smoking and high sugar intake lead to unwanted facial lines. Therefore, aforementioned factors are projected to propel the product demand for facial line corrections in the upcoming period, thereby fueling revenue size.
North America Market, By End-use
Dermatology clinics segment will foresee 7.0% CAGR during projection period and constituted for substantial share in 2019. Dermatological clinics offer specialized services catering to specific conditions of customers. Expertise in these settings and well-equipped facilities with integrated advanced technologies impel segment growth. Expanding network of dermatology clinics with increasing prevalence of skin conditions will further foster the segment growth.
North America Market, By Country
U.S dermal filler market was valued at over USD 1.5 billion by 2019. Considerable revenue size is primarily attributable to increasing product demand with procedural volume. Growing out of pocket expenditure, awareness, focus on facial aesthetics and preference for minimally invasive procedures are some of the growth driving factors. According to the American Society of Plastic Surgeons, about 17.7 million cosmetic procedures were performed in 2018 while more than 15 million were minimally invasive procedures. Furthermore, presence of extensive treatment facilities network and skilled plastic surgeons will propel the market growth.
Competitive Market Share
Some of the major industry players involved in North America dermal filler market include Allergan Plc. (AbbVie), Merz Pharma GmbH & Co. KGaA, Galderma, Prollenium Medica Technologies and Sinclair Pharma among other players. These key players are undertaking various strategies such as collaborations and mergers & acquisitions to sustain market competition and explore the untapped business potential. For instance, in September 2019, Allergan plc announced the approval for Juvéderm VOLUMA XC, HA gel dermal filler with TSK STERiGLIDE cannula from the U.S. FDA for cheek augmentation. The filler is intended for use in correction of age-associated volume deficit in people aged above 21 years. This strategy has helped the company in expanding footprint in dermal filler market.
During 19th century, augmentation with soft tissue fillers included injection of paraffin in a patients with advanced tuberculosis and autologous fat harvested from the arms for correction of facial defects. Later, range of dermal fillers have been approved since first FDA approved Bovine collagen cosmetic injectable in 1981. From 2003, the FDA started to approve fillers for temporary soft tissue augmentation. With research and development, new synthetic fillers such as calcium poly-L-lactic acid and calcium hydroxylapatite were introduced with long-term durability. The advancements in fillers has led to increasing product approvals with variety of materials including hyaluronic acid, man-made or synthetic polymers. With growing aesthetics industry and improvement in filler material, the dermal filler business in the region is projected to witness robust growth in future.